May 30, 2017 12:20 AM ET

Biotechnology

Company Overview of Rani Therapeutics, LLC

Company Overview

Rani Therapeutics, LLC develops oral biotherapeutics technologies for the oral delivery of large drug molecules that include peptides, proteins, and antibodies. It offers TNFa Inhibitors that are used for treatment of inflammatory disorders, including rheumatoid arthritis and Crohn's disease; Parathyroid Hormone for the treatment of osteoporosis; Human Growth Hormone, a peptide hormone that stimulates growth, cell reproduction, and regeneration, as well as is used in the treatment of growth disorders and growth deficiency; and Somatostatin, a growth hormone-inhibiting hormone that is used to treat various indications, including enteroendocrine tumors (in the stomach, intestine, or pancreas),...

2051 Ringwood Avenue

San Jose, CA 95131

United States

Founded in 2012

Phone:

408-457-3712

Key Executives for Rani Therapeutics, LLC

Chairman and Chief Executive Officer
Vice President of Operations
Vice President of Business Development
Vice President of Research & Development
Compensation as of Fiscal Year 2016.

Rani Therapeutics, LLC Key Developments

Rani Therapeutics Appoints Maulik Nanavaty to its Board of Directors

Rani Therapeutics appointed Maulik Nanavaty to its board of directors. Nanavaty is currently Senior vice president and President of Boston Scientific's Neuromodulation Division and a member of its Executive Committee. Prior to his eleven year tenure at Boston Scientific, Nanavaty held various executive positions at Baxter International Inc. and Baxter Japan.

David Pyott Joins Rani Therapeutics Board

Rani Therapeutics announced that seasoned pharmaceutical executive, Dr. David Pyott, is joining its Board. Dr. Pyott is formerly the Chairman and Chief Executive Offer of Allergan. Dr. Pyott is a member of the Boards of Avery Dennison Corporation, Bioniz Therapeutics, BioMarin Pharmaceutical, Alnylam Pharmaceuticals, and a member of the Supervisory Board of Royal Philips in the Netherlands. He is a member of the Governing Board of the London Business School, President of the International Council of Ophthalmology Foundation, and a member of the Advisory Board of the Foundation of the American Academy of Ophthalmology.

Rani Therapeutics Hires Robert Gaffney as Vice President of Operations

As part of its next stage of growth, Rani Therapeutics recently hired Robert Gaffney as Vice President of Operations to lead the company's expansion.Gaffney joined from Spinal Modulation, an InCube Labs company acquired by St. Jude Medical in 2015, where he served as Chief Operating Officer.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rani Therapeutics, LLC, please visit www.ranitherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.